CSANZ 2020: Cardiovascular Nursing Lecture

Prof Robyn Clark, Professor Acute Care and Cardiovascular Research at Flinders University

Cardiovascular Nursing Lecture :  Is ACCESS a risk factor for cardiovascular disease?

(click above link to view)

Biography

Prof Robyn Clark is a senior clinician and mid-career researcher; she holds qualifications as a Registered Nurse, Registered Midwife and Critical Care Nurse, a Master’s degree in Education and a PhD. Prof Clark is a Heart Foundation Future Leader Fellow (2016-2019), a Fellow of the Royal College of Nursing, Fellow of the American Heart Association and Life Member of the Australian College of Critical Care Nurses. Prof Clark was the inaugural recipient of a National Institute of Clinical Studies (NICS-NHMRC) PhD scholarship supported by the National Heart Foundation for researching telemonitored heart failure management in rural and remote Australia She completed a NHMRC Australian Training Fellowship at the Queensland University of Technology in 2013 after which she commenced her appointment at Flinders University in as Prof of Acute Care and Cardiovascular Research. Prof Clark currently holds adjunct appointments at the University of South Australia, Queensland University of Technology and the South Australian Health and Medical Research Institute (SAHMRI). Prof Robyn Clark is internationally-recognized for her research into the most effective management of patients with heart failure and cardiovascular disease. Prof Clark’s research program can be summarized under the overall theme of increasing ACCESS to evidence-based care for underserviced and disadvantaged populations. Prof Clark’s program of research has three streams: stream one focuses upon improving access the heart failure and cardiovascular disease services for patients and communities especially in rural and remote Australia. This suite of research is recognized for its innovative methods, particularly its emphasis on geographical epidemiological analysis using GIS. The second stream involves the use of information technology to bridge the gap between cardiac specialist centers and populations with limited access to cardiology services or to patients with low health literacy. This suite of research includes the evaluation of telehealth, apps and avatars as tools to deliver education and secondary interventions for heart failure and cardiac rehabilitation. The third theme is centred on improving access for patients with cardiotoxicity after cancer treatment to appropriate cardiac rehabilitation and secondary prevention. Prof Clark has a strong background in epidemiology and linked data analysis and in the last 4 years has been working with cancer researchers in investigate the epidemiology and patient outcome of heart failure after cancer treatment. All of these streams underpin a cohesive research strategy that aims to build capacity in cardiovascular care supported by technology outside of metropolitan hospitals.

CSANZ 2020: Victor Chang Memorial Lecture

Assoc Prof Julie Mundy, Cardiothoracic Surgeon, Princess Alexandra Hospital

Victor Chang Memorial Lecture: The changing face of cardiac surgery

(Click above link to view)

Biography

A/Prof Julie Mundy graduated in medicine from the University of Queensland in 1982. She trained in general surgery at the Princess Alexandra Hospital followed by cardiothoracic surgery training in Sydney at St. Vincent’s Hospital in adult cardiothoracic surgery and heart-lung transplantation. Further training was obtained in thoracic surgery at The Royal Prince Alfred Hospital and paediatric cardiac surgery at the Royal Children’s Hospital at Camperdown.

After completing her cardiothoracic surgical training in Australia and gaining some overseas experience in Glasgow, Assoc Prof Mundy returned to St. Vincent’s Hospital, Sydney in 1993 as a cardiothoracic and heart-lung transplant surgeon. In 1999 she commenced as the Director of Cardiothoracic Surgery at the Princess Alexandra Hospital and established this new unit. She is actively involved with RACS activities as a Councillor and for the last 4 years has held the executive position of Treasurer.

Her main interests are surgical education, having been involved extensively with trainees of all levels from basic through to advanced training, for over 25 years. She has held the positions of Chair, Surgical Science and Clinical Exam Committee as well as Senior Examiner in Cardiothoracic Surgery for the Fellowship Examination. Her other surgical interest areas are blood usage minimisation, perioperative assessment and optimisation and heart failure surgery.

Prostheses Reform Consultation

The Australian Department of Health is seeking feedback from clinicians and other interested parties on proposed options for reforms and improvements to the Prostheses List.  The Department released two reports which provide context to the Consultation Paper (1.1MB) and facilitate more complete consultation on potential reform options:

Submissions closed on 15 February, 2021.  For updated information please go to the consultation website.

2020 CSANZ ASM & ANZET VIRTUAL : Recommended Podcasts

Listen to some of the recommended Podcasts presented at the 2020 CSANZ ASM and ANZET Virtual Meetings.
Mechanisms and Preclinical Discovery Podcast: ECI Interview Re: Mentorship

Nicola Sergienko, PhD student interviews Dr Laura Bienvenu, Research Officer and Dr Alexander Pinto, Laboratory Head, all at the Baker Heart and Diabetes Institute in Melbourne.

Listen to Podcast

Clinical / Surgical Podcast: Meet the Expert

Prof Derek Chew (SAHMRI) interviews Prof Nick Mills (Consultant Cardiologist from Royal Infirmary of Edinburgh)

Mechanisms and Preclinical Discovery Podcast: ECI Interview re Challenges for Women in CVD research 

Priscilla Prestes, PhD student interviews Dr Michelle Maier Postgraduate Researcher both of Federation University and also Dr Kate Weeks, Baker Heart and Diabetes Institute.

Listen to podcast

Click the Podcast links below to enjoy all the podcasts created for the 2020 CSANZ ASM.

Boston Scientific: Model A209 Emblem™ S-ICDs & Model A219 Emblem MRI™ (S-ICDs) (21 Dec 2020)

 expanding RC-2019-RN-01242-1 device population with increased likelihood of a low voltage capacitor causing accelerated battery depletion

ANZCDACC Safety Alert Notice 21 December 2020

Device:

  1. Model A209 EMBLEM ™ Subcutaneous Implantable Cardioverter Defibrillators (S-ICDs)
  2. Model A219 EMBLEM MRI™ Subcutaneous Implantable Cardioverter Defibrillators (S-ICDs)

 

ARTG:

  1. 260382
  2. 286705

Medsafe Reference Number: 26965

TGA Reference: RC-2020-RN-01312-1

download as pdf

Boston Scientific EMBLEM™ S-ICDs (Models A209 and A219) Implanted – May 2015 to Dec 2017 (6 December 2020)

Over time a pathway may develop in header that allows moisture ingress, enabling a shorting condition to occur during delivery of HV therapy

Device: EMBLEM™ Subcutaneous Implantable Cardioverter Defibrillators (S-ICDs) (Models A209 and A219) all Implanted from May 2015 to December 2017

6 December 2020

 Advisory grade TGA: TBA

 

Download as pdf

LivaNova Platinium ICD and CRTD (July 2018)

ANZCDACC Advisory Notice 2nd August 2018

Download pdf

Device:

LivaNova:  Limited subset of Platinium ICD and CRTD

(Platinium VR 1210, Platinium VR 1240, Platinium DR 1510, Platinium DR 1540, Platinium CRT-D 1711, Platinium CRT-D 1741, Platinium SONR CRT-D 1811, Platinium SONR CRT-D 1841.)

Serial numbers of affected devices in Australia: 629DL05C, 650DL087, 638DD149, 639DD140, 639DD15E, 624DF096

TGA Reference: RC-2018-RN-00929-1

Australian Register of Therapeutic Goods (ARTG): 282817, 282816, 282818, 282819, 282820, 282821, 282822, 282823 respectively.

Posts navigation